Adicet Bio ACET Stock
Adicet Bio Price Chart
Adicet Bio ACET Financial and Trading Overview
| Adicet Bio stock price | 2.13 USD |
| Previous Close | 4.53 USD |
| Open | 4.51 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 800 |
| Day's Range | 4.4 - 4.7 USD |
| 52 Week Range | 4.4 - 21.87 USD |
| Volume | 465.61K USD |
| Avg. Volume | 450.6K USD |
| Market Cap | 194.6M USD |
| Beta (5Y Monthly) | 1.916948 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.31 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 27.56 USD |
ACET Valuation Measures
| Enterprise Value | -13545135 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.7356323 |
| PEG Ratio (5 yr expected) | -0.06 |
| Price/Sales (ttm) | Infinity |
| Price/Book (mrq) | 0.7309989 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.126 |
Trading Information
Adicet Bio Stock Price History
| Beta (5Y Monthly) | 1.916948 |
| 52-Week Change | -61.34% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 21.87 USD |
| 52 Week Low | 4.4 USD |
| 50-Day Moving Average | 5.89 USD |
| 200-Day Moving Average | 10.59 USD |
ACET Share Statistics
| Avg. Volume (3 month) | 450.6K USD |
| Avg. Daily Volume (10-Days) | 431.61K USD |
| Shares Outstanding | 42.96M |
| Float | 24.11M |
| Short Ratio | 9.8 |
| % Held by Insiders | 3.30% |
| % Held by Institutions | 105.06% |
| Shares Short | 3.11M |
| Short % of Float | 9.81% |
| Short % of Shares Outstanding | 7.23% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -21.41% |
| Return on Equity (ttm) | -36.47% |
Income Statement
| Revenue (ttm) | 0 USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 24.99M USD |
| EBITDA | -107102000 USD |
| Net Income Avi to Common (ttm) | -105289000 USD |
| Diluted EPS (ttm) | -2.32 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 231.64M USD |
| Total Cash Per Share (mrq) | 5.39 USD |
| Total Debt (mrq) | 23.5M USD |
| Total Debt/Equity (mrq) | 8.83 USD |
| Current Ratio (mrq) | 12.976 |
| Book Value Per Share (mrq) | 6.197 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -72964000 USD |
| Levered Free Cash Flow (ttm) | -57159500 USD |
Profile of Adicet Bio
| Country | United States |
| State | MA |
| City | Boston |
| Address | 200 Berkeley Street |
| ZIP | 02116 |
| Phone | 650 503 9095 |
| Website | https://www.adicetbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 132 |
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and chimeric adaptors to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also develops ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors; and ADI-925, a novel engineered CAd gamma delta T cell product candidate targeting tumor stress ligands. Adicet Bio, Inc. is based in Boston, Massachusetts.
Q&A For Adicet Bio Stock
What is a current ACET stock price?
Adicet Bio ACET stock price today per share is 2.13 USD.
How to purchase Adicet Bio stock?
You can buy ACET shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Adicet Bio?
The stock symbol or ticker of Adicet Bio is ACET.
Which industry does the Adicet Bio company belong to?
The Adicet Bio industry is Biotechnology.
How many shares does Adicet Bio have in circulation?
The max supply of Adicet Bio shares is 83.31M.
What is Adicet Bio Price to Earnings Ratio (PE Ratio)?
Adicet Bio PE Ratio is now.
What was Adicet Bio earnings per share over the trailing 12 months (TTM)?
Adicet Bio EPS is -3.31 USD over the trailing 12 months.
Which sector does the Adicet Bio company belong to?
The Adicet Bio sector is Healthcare.
Adicet Bio ACET included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}